Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-011224
Filing Date
2019-06-21
Accepted
2019-06-21 16:31:41
Documents
112
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2019_elitepharma.htm 10-K 1808978
2 LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT EFFECTIVE APRIL 9, 2019 BY AND BETWEE f10k2019ex10-49_elitepharma.htm EX-10.49 388493
3 LICENSE, SUPPLY AND DISTRIBUTION AGREEMENT EFFECTIVE MARCH 6, 2019 BY AND BETWEE f10k2019ex10-50_elitepharma.htm EX-10.50 254172
4 DEVELOPMENT AGREEMENT EFFECTIVE DECEMBER 3, 2018 BY AND BETWEEN MIKAH PHARMA LLC f10k2019ex10-51_elitepharma.htm EX-10.51 70330
5 SUBSIDIARY OF THE COMPANY f10k2019ex21_elite.htm EX-21 857
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2019ex23-1_elite.htm EX-23.1 3170
7 CERTIFICATION f10k2019ex31-1_elite.htm EX-31.1 9537
8 CERTIFICATION f10k2019ex31-2_elite.htm EX-31.2 9542
9 CERTIFICATION f10k2019ex32-1_elite.htm EX-32.1 3945
10 CERTIFICATION f10k2019ex32-2_elite.htm EX-32.2 3882
17 GRAPHIC image_001.jpg GRAPHIC 13485
  Complete submission text file 0001213900-19-011224.txt   7607444

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE eltp-20190331.xml EX-101.INS 1033652
12 XBRL SCHEMA FILE eltp-20190331.xsd EX-101.SCH 86763
13 XBRL CALCULATION FILE eltp-20190331_cal.xml EX-101.CAL 72643
14 XBRL DEFINITION FILE eltp-20190331_def.xml EX-101.DEF 308180
15 XBRL LABEL FILE eltp-20190331_lab.xml EX-101.LAB 526552
16 XBRL PRESENTATION FILE eltp-20190331_pre.xml EX-101.PRE 437791
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 19911902
SIC: 2834 Pharmaceutical Preparations